Loeb's Calls For Acorda Therapeutics (ACOR) To Sell
Daniel S. Loeb's Third Point LLC sent a letter to Acorda Therapeutics (Nasdaq: ACOR) stating the Board of Directors should immediately retain an investment bank and pursue a process to sell the Company in its entirety
Labels: ACOR, Acorda Therapeutics
0 Comments:
Post a Comment
<< Home